000			02278 a2200649 4500
005			20250517151151.0
264		0	_c20180309
008			201803s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.15994 _2doi
040			_aNLM _beng _cNLM
100	1		_aWen, Kuo-Chang
245	0	0	_aα2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells. _h[electronic resource]
260			_bOncotarget _cApr 2017
300			_a29013-29027 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aBiomarkers, Tumor _xantagonists & inhibitors
650	0	4	_aCarcinoma, Ovarian Epithelial
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aImmunoprecipitation
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMicroarray Analysis
650	0	4	_aNeoplasm Invasiveness _xpathology
650	0	4	_aNeoplasm Staging
650	0	4	_aNeoplasms, Glandular and Epithelial _xmortality
650	0	4	_aOleanolic Acid _xanalogs & derivatives
650	0	4	_aOvarian Neoplasms _xmortality
650	0	4	_aOvary _xpathology
650	0	4	_aPeritoneal Neoplasms _xsecondary
650	0	4	_aPeritoneum _xpathology
650	0	4	_aPrognosis
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aSaponins _xpharmacology
650	0	4	_aSialyltransferases _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSurvival Rate
650	0	4	_abeta-Galactoside alpha-2,3-Sialyltransferase
700	1		_aSung, Pi-Lin
700	1		_aHsieh, Shie-Liang
700	1		_aChou, Yu-Ting
700	1		_aLee, Oscar Kuang-Sheng
700	1		_aWu, Cheng-Wen
700	1		_aWang, Peng-Hui
773	0		_tOncotarget _gvol. 8 _gno. 17 _gp. 29013-29027
856	4	0	_uhttps://doi.org/10.18632/oncotarget.15994 _zAvailable from publisher's website
999			_c27094694 _d27094694